Determinations

On the basis of the record ^[1] developed in the subject investigations, the United States International Trade Commission (“Commission”) determines, pursuant to the Tariff Act of 1930 (“the Act”), that an industry in the United States is materially injured by reason of imports of L-lysine (“lysine”) from China, provided for in subheading 2922.41.00 of the Harmonized Tariff Schedule of the United States, that have been found by the U.S. Department of Commerce (“Commerce”) to be sold in the United States at less than fair value (“LTFV”), and imports of the subject merchandise from China that have been found to be subsidized by the government of China.^[2 3]

Background

The Commission instituted these investigations effective May 28, 2025, following receipt of petitions filed with the Commission and Commerce by Archer Daniels Midland Company (“ADM”), Chicago, Illinois; CJ Bio America, Inc., an Iowa Corporation (“CJ Bio”), Fort Dodge, Iowa; and Evonik Corporation (“Evonik”), Piscataway, NJ. The final phase of the investigations was scheduled by the Commission following notification of preliminary determinations by Commerce that imports of lysine from China were subsidized within the meaning of section 703(b) of the Act (19 U.S.C. 1671b(b)) and sold at LTFV within the meaning of 733(b) of the Act (19 U.S.C. 1673b(b)). Notice of the scheduling of the final phase of the Commission's investigations and of a public hearing to be held in connection therewith was given by posting copies of the notice in the Office of the Secretary, U.S. International Trade Commission, Washington, DC, and by publishing the notice in the Federal Register on April 3, 2026 (91 FR 16967). The public hearing in connection with the investigations, originally scheduled for July 14, 2026, was cancelled.^[4]

The Commission made these determinations pursuant to §§ 705(b) and 735(b) of the Act (19 U.S.C. 1671d(b) and 19 U.S.C. 1673d(b)). It completed and filed its determinations in these investigations on September 2, 2026. The views of the Commission are contained in USITC Publication 5783 (September 2026), entitled L-Lysine from China: Investigation Nos. 701-TA-767 and 731-TA-1750 (Final).